Word

Status

Registered

Status Code

700

Status Date

Tuesday, June 19, 2018

Serial Number

79200117

Registration Number

5494415

Registration Date

Tuesday, June 19, 2018

Mark Type

2000

Filing Date

Wednesday, October 5, 2016

Published for Opposition

Tuesday, April 3, 2018

Trademark Owner History

Boehringer Ingelheim International GmbH - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; preparations for health care in the nature of medical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; bacteriological preparations for medical and veterinary use; biological preparations for medical and for veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; biochemical preparations for medical and veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; Chemical preparations for medical purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; ferments for pharmaceutical purposes; vaccines; culture media for cultivating microorganism cells for biotechnological research and manufacturing; plasters and dressings for medical purposes

1 Chemical, biochemical and biological products, substances and preparations, namely, reagents, antibodies, proteins, nucleic acids, fusion proteins, stem cells, and gene therapy preparations for industrial, scientific and research purposes

44 Medical and veterinary consulting; providing medical and veterinary information via the Internet; all the aforementioned consultations and services also provided through a database; providing medical information via the Internet

42 Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatments in the fields of biotechnology, development of active medical substances, medicines, pharmaceuticals, and biotechnology; research and development of new products in the field of biotechnology; technical and scientific consultancy in the field of biotechnology; conducting clinical trials for others in the field of pharmaceutical products

The mark consists of three hexagonal designs, which are formed by twenty-three varying geometric shapes. The bottom hexagonal design is featured in purple, the hexagonal design featured above and to the left of the bottom hexagonal design is featured in green, and the hexagonal design featured above and to the right of the bottom hexagonal design is featured in blue.
The color(s) blue, green and purple is/are claimed as a feature of the mark.

Trademark Events

Jun 19, 2023

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 12, 2018

Final Decision Transaction Processed By Ib

Sep 21, 2018

Final Disposition Notice Sent To Ib

Sep 21, 2018

Final Disposition Processed

Sep 19, 2018

Final Disposition Notice Created, To Be Sent To Ib

Jun 29, 2018

Notification Of Possible Opposition - Processed By Ib

Jun 19, 2018

Registered-Principal Register

Jun 14, 2018

Notification Of Possible Opposition Sent To Ib

Jun 14, 2018

Notification Of Possible Opposition Created, To Be Sent To Ib

Apr 3, 2018

Official Gazette Publication Confirmation E-Mailed

Apr 3, 2018

Published For Opposition

Mar 30, 2018

Notification Processed By Ib

Mar 14, 2018

Notification Of Possible Opposition Sent To Ib

Mar 14, 2018

Notification Of Notice Of Publication E-Mailed

Mar 14, 2018

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 1, 2018

Law Office Publication Review Completed

Feb 27, 2018

Assigned To Lie

Feb 21, 2018

Approved For Pub - Principal Register

Feb 21, 2018

Examiner's Amendment Entered

Feb 21, 2018

Notification Of Examiners Amendment E-Mailed

Feb 21, 2018

Examiners Amendment E-Mailed

Feb 21, 2018

Examiners Amendment -Written

Feb 15, 2018

Previous Allowance Withdrawn-Timely Aau

Jan 30, 2018

Withdrawn From Pub - Og Review Query

Jan 9, 2018

Exparte Appeal Terminated

Jan 9, 2018

Approved For Pub - Principal Register

Jan 5, 2018

Examiner's Amendment Entered

Jan 5, 2018

Notification Of Examiners Amendment E-Mailed

Jan 5, 2018

Examiners Amendment E-Mailed

Jan 5, 2018

Examiners Amendment -Written

Dec 22, 2017

Teas Request For Reconsideration Received

Dec 22, 2017

Ex Parte Appeal-Instituted

Dec 22, 2017

Jurisdiction Restored To Examining Attorney

Dec 22, 2017

Exparte Appeal Received At Ttab

Jun 22, 2017

Notification Of Final Refusal Emailed

Jun 22, 2017

Final Refusal E-Mailed

Jun 22, 2017

Final Refusal Written

May 25, 2017

Teas/Email Correspondence Entered

May 25, 2017

Correspondence Received In Law Office

May 25, 2017

Teas Response To Office Action Received

May 22, 2017

Teas Change Of Correspondence Received

Feb 18, 2017

Refusal Processed By Ib

Jan 25, 2017

Non-Final Action Mailed - Refusal Sent To Ib

Jan 25, 2017

Refusal Processed By Mpu

Jan 20, 2017

Non-Final Action (Ib Refusal) Prepared For Review

Jan 19, 2017

Non-Final Action Written

Jan 19, 2017

Non-Final Action (Ib Refusal) Withdrawn For Review

Jan 17, 2017

Application Filing Receipt Mailed

Jan 14, 2017

Non-Final Action (Ib Refusal) Prepared For Review

Jan 13, 2017

Non-Final Action Written

Jan 13, 2017

Assigned To Examiner

Jan 13, 2017

New Application Office Supplied Data Entered

Jan 12, 2017

Sn Assigned For Sect 66a Appl From Ib